Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Despite its known correlations with risk of cardiovascular disease, awareness and testing for Lipoprotein (a) lags that of other serological markers with estimates that less than 1% of the US population have undergone screening.

Cardiovascular Disease 52

Cardiovascular Disease Biomarkers Obesity Outcomes 52

Frontiers in Cardiovascular Medicine

JULY 17, 2024

The triglyceride–glucose (TyG) index, proven to be a crucial insulin resistance biomarker (better than the Homeostasis Model Assessment for Insulin Resistance), is simple and non-invasive. Finally, we summarized the mechanism of the “obesity paradox.”

Heart Failure 64

Heart Failure Atherosclerosis Biomarkers Obesity 64

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 100

Education Innovation Risk Factors Obesity 100

Cardiometabolic Health Congress

OCTOBER 25, 2024

He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Aronne, MD , discussed advances in obesity pharmacology, while Virend K.

CME 64

CME Innovation Education Atherosclerosis 64

Circulation: Cardiovascular Quality & Outcomes

OCTOBER 20, 2023

BACKGROUND:The relationship between marijuana use and cardiovascular health remains uncertain, with several observational studies suggesting a potential association with increased adverse atherosclerotic cardiovascular disease (ASCVD) outcomes. P=0.84), obesity (35.8% female; 13% non-Hispanic Black), 26.6% versus 18.8%,P=0.76;

Risk Factors 40

Risk Factors Cardiovascular Disease Cholesterol Biomarkers 40

Dr. Paddy Barrett

FEBRUARY 21, 2025

For over 50 years, rates of those who are overweight or obese have been rising rapidly. Despite the rise in obesity rates, the growing recognition of it as a global problem and the astronomical sums of money we spend on addressing it, the tide continues to rise. That is until now.

Obesity 81

Obesity Diabetes Cardiovascular Disease Chronic Disease 81

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111